{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q13201",
      "entity_text" : "ECM",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ07062",
      "entity_text" : "PJ34",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Treatment with the PARP1/2 enzyme inhibitor PJ34 blocked calcification at day 18 and dramatically reduced PAR deposition in the ECM, although there was some residual PAR co-localizing with CD63 (XREF_FIG A).",
  "reading_complete" : "2020-08-08T14:50:09Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T14:42:49Z",
  "trigger" : "reduced",
  "evidence" : [ "PJ34 blocked calcification at day 18 and dramatically reduced PAR deposition in the ECM" ],
  "pmc_id" : "6581741",
  "score" : 0
}